{"id":"https://openalex.org/W1976359149","doi":"https://doi.org/10.1007/s00280-005-0064-x","title":"Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer","display_name":"Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer","publication_year":2005,"publication_date":"2005-09-28","ids":{"openalex":"https://openalex.org/W1976359149","doi":"https://doi.org/10.1007/s00280-005-0064-x","mag":"1976359149","pmid":"https://pubmed.ncbi.nlm.nih.gov/16193332"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-005-0064-x","doi":"https://doi.org/10.1007/s00280-005-0064-x","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-005-0064-x","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063680924","display_name":"Silwan Chedid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Silwan Chedid","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103745486","display_name":"Edgardo Rivera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edgardo Rivera","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113654117","display_name":"Debbie K. Frye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debbie K. Frye","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077026571","display_name":"Nuhad K. Ibrahim","orcid":"https://orcid.org/0000-0001-8660-243X","observed_orcids":["https://orcid.org/0000-0001-8660-243X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nuhad Ibrahim","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087724207","display_name":"Francisco J. Esteva","orcid":"https://orcid.org/0000-0003-2437-3920","observed_orcids":["https://orcid.org/0000-0003-2437-3920"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francisco Esteva","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080832682","display_name":"Vicente Valero","orcid":"https://orcid.org/0000-0001-5913-7480","observed_orcids":["https://orcid.org/0000-0001-5913-7480"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vicente Valero","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018617106","display_name":"Gabriel N. Hortob\u00e1gyi","orcid":"https://orcid.org/0000-0002-4873-4412","observed_orcids":["https://orcid.org/0000-0002-4873-4412"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel Hortobagyi","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087028329","display_name":"Karl L. Mettinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karl L. Mettinger","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032987754","display_name":"Massimo Cristofanilli","orcid":"https://orcid.org/0000-0002-4194-7175","observed_orcids":["https://orcid.org/0000-0002-4194-7175"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Massimo Cristofanilli","raw_affiliation_strings":["Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","SuperGen, Inc., Dublin, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"SuperGen, Inc., Dublin, CA, USA","institution_ids":["https://openalex.org/I4210149223"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032987754"],"corresponding_institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210149223"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.1247,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.45214845,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"57","issue":"4","first_page":"540","last_page":"544"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6323000192642212,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6323000192642212,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.3312999904155731,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/camptothecin-analogs","display_name":"camptothecin analogues","score":0.8100000023841858},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/heavily-pretreated-patients","display_name":"heavily pretreated patients","score":0.9670000076293945},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/single-agent-chemotherapy","display_name":"single-agent chemotherapy","score":0.6430000066757202},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7409999966621399},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.9279999732971191},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.47999998927116394},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6169224977493286},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.540276825428009},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5330812931060791},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48141050338745117},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4767882823944092},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3938218355178833}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00280-005-0064-x","doi":"https://doi.org/10.1007/s00280-005-0064-x","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-005-0064-x","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:16193332","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16193332","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8399999737739563}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W354145976","https://openalex.org/W1565731923","https://openalex.org/W1587797958","https://openalex.org/W1774923611","https://openalex.org/W1812067939","https://openalex.org/W1918151945","https://openalex.org/W2015159040","https://openalex.org/W2029409133","https://openalex.org/W2058114203","https://openalex.org/W2065151056","https://openalex.org/W2065401544","https://openalex.org/W2067024881","https://openalex.org/W2068776651","https://openalex.org/W2100052442","https://openalex.org/W2111976640","https://openalex.org/W2119541084","https://openalex.org/W2123732467","https://openalex.org/W2125623164","https://openalex.org/W2125687735","https://openalex.org/W2125889174","https://openalex.org/W2149246104","https://openalex.org/W2398845930","https://openalex.org/W2401586889","https://openalex.org/W2408791611","https://openalex.org/W2412532798","https://openalex.org/W2414246616","https://openalex.org/W2419655738","https://openalex.org/W3145402682"],"related_works":["https://openalex.org/W1972362283","https://openalex.org/W2125930061","https://openalex.org/W2075771794","https://openalex.org/W2245930256","https://openalex.org/W2072256594","https://openalex.org/W2753298873","https://openalex.org/W2594586947","https://openalex.org/W2336179584","https://openalex.org/W2106804959","https://openalex.org/W1971473564"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-05T09:50:58.205359","created_date":"2016-06-24T00:00:00"}